首页> 美国卫生研究院文献>The Journal of Neuroscience >Free-Operant Avoidance Behavior by Rats after Reinforcer Revaluation Using Opioid Agonists and d-Amphetamine
【2h】

Free-Operant Avoidance Behavior by Rats after Reinforcer Revaluation Using Opioid Agonists and d-Amphetamine

机译:使用类鸦片激动剂和d-苯丙胺对强化剂进行重估后大鼠的自由操作回避行为

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The associative processes that support free-operant instrumental avoidance behavior are still unknown. We used a revaluation procedure to determine whether the performance of an avoidance response is sensitive to the current value of the aversive, negative reinforcer. Rats were trained on an unsignaled, free-operant lever press avoidance paradigm in which each response avoided or escaped shock and produced a 5 s feedback stimulus. The revaluation procedure consisted of noncontingent presentations of the shock in the absence of the lever either paired or unpaired with systemic morphine and in a different cohort with systemic d-amphetamine. Rats were then tested drug free during an extinction test. In both the d-amphetamine and morphine groups, pairing of the drug and shock decreased subsequent avoidance responding during the extinction test, suggesting that avoidance behavior was sensitive to the current incentive value of the aversive negative reinforcer. Experiment 2 used central infusions of D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAMGO), a mu-opioid receptor agonist, in the periacqueductal gray and nucleus accumbens shell to revalue the shock. Infusions of DAMGO in both regions replicated the effects seen with systemic morphine. These results are the first to demonstrate the impact of revaluation of an aversive reinforcer on avoidance behavior using pharmacological agents, thereby providing potential therapeutic targets for the treatment of avoidance behavior symptomatic of anxiety disorders.
机译:支持自由操作的工具回避行为的关联过程仍然未知。我们使用了重新评估程序来确定回避响应的性能是否对厌恶的负强化剂的当前值敏感。在无信号,自由操作的杠杆按压避免范例下训练大鼠,在这种范例中,每种反应都避免或逃避了电击,并产生了5 s的反馈刺激。重估程序包括非偶然性的休克表现,即没有与全身性吗啡配对或不配对的杠杆,以及与全身性d-苯丙胺不同的队列。然后在灭绝测试中对大鼠进行无药物测试。在d-苯丙胺和吗啡组中,药物和休克的配对减少了消光试验期间随后的回避反应,这表明回避行为对厌恶性负强化剂的当前激励值敏感。实验2使用了D-Ala 2 ,NMe-Phe 4 ,Gly-ol 5 ]-脑啡肽(DAMGO), -阿片受体激动剂,在水囊周围灰质和伏隔核壳中重估休克。在两个区域中注入DAMGO均可复制全身性吗啡所见的效果。这些结果是第一个证明使用药物将厌恶性补强剂重新评估对逃避行为的影响的方法,从而为焦虑症的逃避行为症状的治疗提供了潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号